151 related articles for article (PubMed ID: 20931434)
1. Effects of a long-acting somatostatin analogue, lanreotide, on bile duct ligation-induced liver fibrosis in rats.
Tahan G; Eren F; Tarçin O; Akin H; Tahan V; Şahın H; Özdoğan O; İmeryüz N; Çelıkel Ç; Avşar E; Tözün N
Turk J Gastroenterol; 2010 Sep; 21(3):287-92. PubMed ID: 20931434
[TBL] [Abstract][Full Text] [Related]
2. The effects of pegylated interferon alpha 2b on bile-duct ligation induced liver fibrosis in rats.
Canbakan B; Akin H; Tahan G; Tarcin O; Eren F; Atug O; Tahan V; Imeryuz N; Yapicier O; Avsar E; Tozun N
Ann Hepatol; 2009; 8(3):234-40. PubMed ID: 19841503
[TBL] [Abstract][Full Text] [Related]
3. The effects of N-acetylcysteine on bile duct ligation-induced liver fibrosis in rats.
Tahan G; Tarcin O; Tahan V; Eren F; Gedik N; Sahan E; Biberoglu N; Guzel S; Bozbas A; Tozun N; Yucel O
Dig Dis Sci; 2007 Dec; 52(12):3348-54. PubMed ID: 17436097
[TBL] [Abstract][Full Text] [Related]
4. Melatonin ameliorates liver fibrosis induced by bile-duct ligation in rats.
Tahan G; Akin H; Aydogan F; Ramadan SS; Yapicier O; Tarcin O; Uzun H; Tahan V; Zengin K
Can J Surg; 2010 Oct; 53(5):313-8. PubMed ID: 20858375
[TBL] [Abstract][Full Text] [Related]
5. Effect of tetrandrine on experimental hepatic fibrosis induced by bile duct ligation and scission in rats.
Park PH; Nan JX; Park EJ; Kang HC; Kim JY; Ko G; Sohn DH
Pharmacol Toxicol; 2000 Dec; 87(6):261-8. PubMed ID: 11140824
[TBL] [Abstract][Full Text] [Related]
6. One-year follow-up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel.
Caron P; Bex M; Cullen DR; Feldt-Rasmussen U; Pico Alfonso AM; Pynka S; Racz K; Schopohl J; Tabarin A; Valimaki MJ;
Clin Endocrinol (Oxf); 2004 Jun; 60(6):734-40. PubMed ID: 15163338
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats.
Işeri SO; Sener G; Saglam B; Ercan F; Gedik N; Yeğen BC
Regul Pept; 2008 Feb; 146(1-3):73-9. PubMed ID: 17884193
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of the roots extract of Platycodon grandiflorum on bile duct ligation-induced hepatic fibrosis in rats.
Lim JH; Kim TW; Song IB; Park SJ; Kim MS; Cho ES; Jung JY; Son HY; Kim JW; Yun HI
Hum Exp Toxicol; 2013 Nov; 32(11):1197-205. PubMed ID: 23424213
[TBL] [Abstract][Full Text] [Related]
9. Effects of nebivolol on liver fibrosis induced by bile duct ligation in Wistar rats.
Teixeira C; Franco E; Oliveira PA; Colaço B; Gama A; Carrola J; Pires CA; Colaço A; Pires MJ
In Vivo; 2013; 27(5):635-40. PubMed ID: 23988899
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
Karimian G; Mohammadi-Karakani A; Sotoudeh M; Ghazi-Khansari M; Ghobadi G; Shakiba B
Biomed Pharmacother; 2008 Jun; 62(5):312-6. PubMed ID: 18191530
[TBL] [Abstract][Full Text] [Related]
11. Effects of methylene blue in reducing cholestatic oxidative stress and hepatic damage after bile-duct ligation in rats.
Aksu B; Umit H; Kanter M; Guzel A; Aktas C; Civelek S; Uzun H
Acta Histochem; 2010 May; 112(3):259-69. PubMed ID: 19217652
[TBL] [Abstract][Full Text] [Related]
12. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat.
Fernández-Martínez E; Pérez-Alvarez V; Tsutsumi V; Shibayama M; Muriel P
Exp Toxicol Pathol; 2006 Aug; 58(1):49-58. PubMed ID: 16617007
[TBL] [Abstract][Full Text] [Related]
13. In vivo inefficiency of pentoxifylline and interferon-alpha on hepatic fibrosis in biliary-obstructed rats: assessment by tissue collagen content and prolidase activity.
Tarçin O; Avşar K; Demirtürk L; Gültepe M; Oktar BK; Ozdoğan OC; Tarçin O; Baloğlu H; Gürbüz AK
J Gastroenterol Hepatol; 2003 Apr; 18(4):437-44. PubMed ID: 12653893
[TBL] [Abstract][Full Text] [Related]
14. Vitamin K1 attenuates bile duct ligation-induced liver fibrosis in rats.
Jiao K; Sun Q; Chen B; Li S; Lu J
Scand J Gastroenterol; 2014 Jun; 49(6):715-21. PubMed ID: 24742111
[TBL] [Abstract][Full Text] [Related]
15. Silymarin-loaded Eudragit(®) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats.
Younis N; Shaheen MA; Abdallah MH
Biomed Pharmacother; 2016 Jul; 81():93-103. PubMed ID: 27261582
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of gastrodin on bile duct ligation-induced hepatic fibrosis in rats.
Zhao S; Li N; Zhen Y; Ge M; Li Y; Yu B; He H; Shao RG
Food Chem Toxicol; 2015 Dec; 86():202-7. PubMed ID: 26498411
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of lanreotide in preventing the occurrence of chemically induced hepatocellular carcinoma in rats.
Borbath I; Leclercq IA; Sempoux C; Abarca-Quinones J; Desaeger C; Horsmans Y
Chem Biol Interact; 2010 Jan; 183(1):238-48. PubMed ID: 19874807
[TBL] [Abstract][Full Text] [Related]
18. [Effect of bile duct ligation and recanalization on rat hepatocyte epithelial-mesenchymal phenotype and NOX4 protein expression].
Lou AN; Pan CQ; Li Y; Yang RQ; Li X
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Oct; 35(10):1457-62. PubMed ID: 26547341
[TBL] [Abstract][Full Text] [Related]
19. Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial.
Gadelha MR; Bronstein MD; Brue T; Coculescu M; Fleseriu M; Guitelman M; Pronin V; Raverot G; Shimon I; Lievre KK; Fleck J; Aout M; Pedroncelli AM; Colao A;
Lancet Diabetes Endocrinol; 2014 Nov; 2(11):875-84. PubMed ID: 25260838
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in the management of acromegaly.
Caron P; Beckers A; Cullen DR; Goth MI; Gutt B; Laurberg P; Pico AM; Valimaki M; Zgliczynski W
J Clin Endocrinol Metab; 2002 Jan; 87(1):99-104. PubMed ID: 11788630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
